AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Katz, R Wagner, HN Fauntleroy, M Kuwert, T Frank, R
Citation: R. Katz et al., The use of imaging as biomarkers in drug development: Regulatory issues worldwide, J CLIN PHAR, 2001, pp. 118S-118S

Authors: Wagner, HN
Citation: Hn. Wagner, Nonimaging detectors in drug development and approval, J CLIN PHAR, 2001, pp. 125S-126S

Authors: Wagner, HN
Citation: Hn. Wagner, Highlights 2000 Lecture - The Internet: The road to smart nuclear medicine, J NUCL MED, 41(8), 2000, pp. 9N

Authors: Wagner, HN
Citation: Hn. Wagner, Hybrid PET/CT machines: Optimized PET machines for the new millennium? Reply, J NUCL MED, 41(5), 2000, pp. 962-963

Authors: Kim, SE Szabo, Z Seki, C Ravert, HT Scheffel, U Dannals, RF Wagner, HN
Citation: Se. Kim et al., Effect of tracer metabolism on PET measurement of [C-11]pyrilamine bindingto histamine H-1 receptors, ANN NUCL M, 13(2), 1999, pp. 101-107

Authors: Wagner, HN
Citation: Hn. Wagner, SNM 1999 - Fused image tomography: An integrating force, J NUCL MED, 40(8), 1999, pp. 13N

Authors: Wagner, HN
Citation: Hn. Wagner, A new look at breast cancer, J NUCL MED, 40(6), 1999, pp. 1009-1010

Authors: Weber, W Young, C Abdel-Dayem, HM Sfakianakis, G Weir, GJ Swaney, CM Gates, M Stokkel, MP Parker, A Hines, H Khanvali, B Liebig, JR Leung, AN Sollitto, R Caputo, G Wagner, HN
Citation: W. Weber et al., Assessment of pulmonary lesions with F-18-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras, J NUCL MED, 40(4), 1999, pp. 574-578

Authors: Wagner, HN
Citation: Hn. Wagner, Fused image tomography: Where do we go from here?, J NUCL MED, 40(10), 1999, pp. 30N
Risultati: 1-9 |